Singapore markets closed

MedTech Acquisition Corporation (MTAC)

NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
10.20-0.08 (-0.78%)
At close: 12:01PM EDT
Full screen
Trade prices are not sourced from all markets
Previous close10.28
Bid10.23 x 800
Ask0.00 x 1400
Day's range10.20 - 10.27
52-week range9.78 - 10.68
Avg. volume816
Market cap83.675M
Beta (5Y monthly)-0.03
PE ratio (TTM)53.68
EPS (TTM)0.19
Earnings dateN/A
Forward dividend & yieldN/A (N/A)
Ex-dividend dateN/A
1y target estN/A
  • Business Wire

    TriSalus Life Sciences Appoints James Alecxih to Lead Device Technology Business

    DENVER & CHICAGO, February 21, 2023--TriSalus Life Sciences®, Inc. ("TriSalus" or the "Company"), an oncology company in the process of going public through a business combination transaction (the "Business Combination") with MedTech Acquisition Corporation (Nasdaq: MTAC) ("MedTech" or "MTAC"), today announced that James "Jim" Alecxih has joined the Company in the newly created role of President, Device Technology Business.